Literature DB >> 17917122

Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

C Hawkes1, A Amritraj, R G Macdonald, J H Jhamandas, S Kar.   

Abstract

The G protein-coupled receptor (GPCR) family represents the largest and most versatile group of cell surface receptors. Classical GPCR signaling constitutes ligand binding to a seven-transmembrane domain receptor, receptor interaction with a heterotrimeric G protein, and the subsequent activation or inhibition of downstream intracellular effectors to mediate a cellular response. However, recent reports on direct, receptor-independent G protein activation, G protein-independent signaling by GPCRs, and signaling of nonheptahelical receptors via trimeric G proteins have highlighted the intrinsic complexities of G protein signaling mechanisms. The insulin-like growth factor-II/mannose-6 phosphate (IGF-II/M6P) receptor is a single-transmembrane glycoprotein whose principal function is the intracellular transport of lysosomal enzymes. In addition, the receptor also mediates some biological effects in response to IGF-II binding in both neuronal and nonneuronal systems. Multidisciplinary efforts to elucidate the intracellular signaling pathways that underlie these effects have generated data to suggest that the IGF-II/M6P receptor might mediate transmembrane signaling via a G protein-coupled mechanism. The purpose of this review is to outline the characteristics of traditional and nontraditional GPCRs, to relate the IGF-II/M6P receptor's structure with its role in G protein-coupled signaling and to summarize evidence gathered over the years regarding the putative signaling of the IGF-II/M6P receptor mediated by a G protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917122     DOI: 10.1007/s12035-007-0021-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  200 in total

Review 1.  GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences.

Authors:  Bukhtiar H Shah; Kevin J Catt
Journal:  Trends Neurosci       Date:  2004-01       Impact factor: 13.837

Review 2.  G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation.

Authors:  Shai Gavi; Elena Shumay; Hsien-yu Wang; Craig C Malbon
Journal:  Trends Endocrinol Metab       Date:  2006-02-07       Impact factor: 12.015

3.  Positive regulation of human T cell activation by Gi2 proteins and interleukin-8.

Authors:  E Lippert; Y Jacques; S Hermouet
Journal:  J Leukoc Biol       Date:  2000-05       Impact factor: 4.962

4.  Basic fibroblast growth factor utilizes both types of component subunits of Gs for dual signaling in human adipocytes. Stimulation of adenylyl cyclase via Galph(s) and inhibition of NADPH oxidase by Gbeta gamma(s).

Authors:  H I Krieger-Brauer; P Medda; H Kather
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid.

Authors:  J X Kang; Y Li; A Leaf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Increase in insulin-like growth factor II receptor within ischemic neurons following focal cerebral infarction.

Authors:  D T Stephenson; K Rash; J A Clemens
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

7.  The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11.

Authors:  N M Dahms; D A Wick; M A Brzycki-Wessell
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

8.  Analysis of stimulation-G protein subunit coupling by using active insulin-like growth factor II receptor peptide.

Authors:  T Okamoto; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

9.  High throughput screening technologies for direct cyclic AMP measurement.

Authors:  Daniela Gabriel; Magali Vernier; Martin J Pfeifer; Boris Dasen; Laurent Tenaillon; Rochdi Bouhelal
Journal:  Assay Drug Dev Technol       Date:  2003-04       Impact factor: 1.738

10.  Expression of the IGF-II/mannose-6-phosphate receptor mRNA and protein in the developing rat.

Authors:  P V Senior; S Byrne; W J Brammar; F Beck
Journal:  Development       Date:  1990-05       Impact factor: 6.868

View more
  9 in total

1.  Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.

Authors:  S Kalla Singh; Q W Tan; C Brito; M De León; D De León
Journal:  Growth Horm IGF Res       Date:  2010-03-27       Impact factor: 2.372

Review 2.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

3.  Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation.

Authors:  Hesham M El-Shewy; Souzan A Abdel-Samie; Abdelmohsen M Al Qalam; Mi-Hye Lee; Kazuyuki Kitatani; Viviana Anelli; Ayad A Jaffa; Lina M Obeid; Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2011-10-20

Review 4.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Authors:  Y Wang; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

5.  Akt1 and insulin-like growth factor 2 (Igf2) regulate placentation and fetal/postnatal development.

Authors:  Lindsey N Kent; Shigeki Ohboshi; Michael J Soares
Journal:  Int J Dev Biol       Date:  2012       Impact factor: 2.203

6.  STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody.

Authors:  Ji-Sun Lee; Ju-Hee Kang; Hye-Jin Boo; Su-Jung Hwang; Sungyoul Hong; Su-Chan Lee; Young-Jun Park; Tae-Moon Chung; Hyewon Youn; Seung Mi Lee; Byoung Jae Kim; June-Key Chung; Yeonseok Chung; William N William; Young Kee Shin; Hyo-Jong Lee; Seung-Hyun Oh; Ho-Young Lee
Journal:  Nat Commun       Date:  2015-10-14       Impact factor: 14.919

7.  Overexpression of the IGF-II/M6P receptor in mouse fibroblast cell lines differentially alters expression profiles of genes involved in Alzheimer's disease-related pathology.

Authors:  Yanlin Wang; Gopal Thinakaran; Satyabrata Kar
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

8.  IGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids.

Authors:  E Martín-Montañez; C Millon; F Boraldi; F Garcia-Guirado; C Pedraza; E Lara; L J Santin; J Pavia; M Garcia-Fernandez
Journal:  Redox Biol       Date:  2017-05-26       Impact factor: 11.799

9.  IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

Authors:  Tiffany J Mellott; Sarah M Pender; Rebecca M Burke; Erika A Langley; Jan Krzysztof Blusztajn
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.